Navigation Links
PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009
Date:5/7/2009

ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the first quarter of 2009 will be released on Thursday, May 14, 2009.

PharmAthene management will be hosting a conference call to discuss its first quarter 2009 financial results. The call is scheduled to begin at 10:00 a.m. Eastern Time on Thursday, May 14, 2009, and is expected to last approximately 45 minutes.

The dial-in number within the United States is 866-783-2137. The dial-in number for international callers is 857-350-1596. The participant passcode is 47746139.

A replay of the conference call will be available beginning at approximately 1:00 p.m. Eastern Time on May 14, 2009 until approximately 11:59 p.m. Eastern Time June 30, 2009. The dial-in number from within the United States is 888-286-8010. For international callers, the dial-in number is 617-801-6888. The participant passcode is 34158052.

The conference call will also be webcast and can be accessed from the company's website at www.PharmAthene.com. A link to the webcast may be found under the Investor Relations section of the website. The webcast will be available for 30 days, or until approximately June 14, 2009.

    Contact:
    Stacey Jurchison
    PharmAthene, Inc.
    Phone: 410-269-2610
    Stacey.Jurchison@PharmAthene.com


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2020)... and CAMBRIDGE, Mass. (PRWEB) , ... February 03, ... ... Budapest with US offices in Cambridge, MA, announce that OmniType, the 11-locus, single ... (EAP) from today. OmniType is a best-in-class product featuring locus-multiplexing and short library ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/24/2020)... PLAINS, N.J. (PRWEB) , ... January 24, 2020 , ... ... at The Plastic Surgery Center in New Jersey epitomize the notion that plastic surgery ... surgery is typically characterized in popular media. , Over the last 20 years NJ ...
(Date:1/23/2020)... (PRWEB) , ... January 22, 2020 , ... ... new developments in the cosmetic surgery industry at two recent North American investor ... investors at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, ...
Breaking Biology Technology:
(Date:2/6/2020)... ... February 06, 2020 , ... ... complex interventional medical device and pharmaceutical trials, announced that Ms. Dorothy Abel ... established role, Dorothy oversees the development and execution of regulatory plans designed ...
(Date:2/5/2020)... ... 05, 2020 , ... LabKey has released Sample Manager, ... sample processing within laboratories. , Built with input from a Product Advisory ... LabKey Sample Manager has been designed with an intuitive user interface providing a ...
(Date:1/29/2020)... ... January 29, 2020 , ... Jason Burke has joined ... practice, providing consulting services for strategy, research and development and data governance to ... and Managing Partner of CREO, an innovative management consulting and advisory firm based ...
Breaking Biology News(10 mins):